The "GLP Laboratory Compliance Documentation and Recordkeeping" training has been added to ResearchAndMarkets.com's offering.
Company remains on track to submit Investigational Device Exemption (“IDE”), and if approved, commence U.S. clinical trials in 2026 to support a De Novo FDA application THE WOODLANDS, TX, Sept. 29, ...
Dear reader, the pharmaceutical industry plays a crucial role in protecting human health, which necessitates stringent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback